Skip to main content
. 2021 Jun;27(6):1627–1636. doi: 10.3201/eid2706.204238

Table 3. Estimated average incidence of otitis media cases and visits averted by PCVs, United States, 1997–2019*.

Measure 1997–1999 2000–2009 2010–2019 Cumulative
Average incidence of visits per 100 children 78 59 46 NA
Expected visits† NA 154,269,900 155,511,917 309,781,817
Estimated visits NA 119,429,938 93,025,190 212,455,128
Visits averted‡ NA 34,839,962 62,486,726 97,326,688

*Values are rounded to the nearest whole numbers. PCV7 was approved for use in the United States in 2000; PCV13 was approved for use in the United States in 2010. NA, not applicable; PCV, pneumococcal conjugate vaccine; PCV7, 7-valent PCV; PCV13, 13-valent PCV.
†Visits expected if PCVs had not been introduced.
‡Calculated by subtracting estimated visits from expected visits.